The role of central and peripheral μ opioid receptors in inflammatory pain and edema: A study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4- oxo-1-phenyl-1,3,8-triazaspiro[ 4.5]dec-3-yl]-acetic acid)

Journal of Pharmacology and Experimental Therapeutics

Volumn 314, Issue 3, 2005, Pages 1234-1240

  Whiteside, Garth T ^a,b   Boulet, Jamie M ^a   Walker, Katharine ^a  

^a Purdue Pharma Discovery Research   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[8 (3,3 DIPHENYLPROPYL) 4 OXO 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DEC 3 YL]ACETIC ACID; ANTIPAIN; CARRAGEENAN; MORPHINE; NALTREXONE DERIVATIVE; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; EDEMA; INFLAMMATION; MALE; NONHUMAN; PAIN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

ACETIC ACIDS; ANIMALS; AZA COMPOUNDS; BRAIN; CARRAGEENAN; EDEMA; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NALTREXONE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SPIRO COMPOUNDS;

EID: 23944487002     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.088351     Document Type: Article

References (40)

1. Alebouyeh M, Pourpak Z, and Ahmadiani A (2002) Increase in serum level of interleukin-1 alpha mediates morphine anti-inflammatory effect in carrageenan-induced paw oedema in mice. Cytokine 19:102-105.
2. Amann R, Lanz I, and Schuligoi R (2002) Effects of morphine on oedema and tissue concentration of nerve growth factor in experimental inflammation of the rat paw. Pharmacology 66:169-172.
3. Antonijevic I, Mouse SA, Schafer M, and Stein C (1995) Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15:165-172.
4. Barber A (1993) μ- and κ-Opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin. Eur J Pharmacol 236:113-120.
5. Bhattacharya SK, Saraswati M, and Sen AP (1992) Effect of centrally administered enkephalins on carrageenin-induced paw oedema in rats. Res Exp Med 192:443-449.
6. Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, and Koppert W (2004) Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg 98:364-370.
7. DeHaven-Hudkins DL, Cowan A, Cortes Burgos L, Daubert JD, Cassel JA, Dehaven RN, Kehner GB, and Kumar V (2002) Antipuritic and antihyperalgesic actions of loperamide and analogs. Life Sci 71:2787-2796.
8. Fecho K, Maslonek KA, Dykstra LA, and Lysle DT (1996) Assessment of the involvement of central nervous system and peripheral opioid receptors in the immuno-modulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 276:626-636.
9. Fields HL and Basbaum AI (1999) Textbook of Pain (Wall PD, Melzack R eds) pp 309-343, Churchill Livingstone, Edinburg, UK.
10. Green PG and Levine JD (1992) δ- and κ-Opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience 49:129-133.
11. Handwerker HO, Anton F, Kocher L, and Reeh PW (1987) Nociceptor functions in intact skin and in neurogenic or no-neurogenic inflammation. Acta Physiol Hung 69:333-342.
12. Hargreaves KM, Dubner R, and Joris J (1988) Peripheral actions of opiates in the blockade of carrageenan-induced inflammation, in Proceeding of the Vth World Congress on Pain (Dubner R, Gebhart GF, and Bond MR eds) pp 55-60, Elsevier Science Publishers, New York.
13. Hong Y and Abbott FV (1995) Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 277:21-28.
14. Ingram SL and Williams JT (1994) Opioid inhibition of Ih via adenylyl cyclase. Neuron 13:179-186.
15. Joris J, Costello A, Dubner R, and Hargreaves KM (1990) Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43:95-103.
16. Kalso E, Tramer MR, Carroll D, McQuay HJ, and Moore RA (1997) Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review. Pain 71:127-134.
17. Ko M, Butelman E, and Woods J (1998) The role of peripheral μ opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther 286:150-156.
18. McDougal JJ, Baker CL, and Hermann PM (2003) Attenuation of knee joint inflammation by peripherally administered endomorphin-1. J Mol Neurosci 22:125-137.
19. Morgan M, Gold M, Liebeskind J, and Stein C (1991) Periaqueductal Gray stimulation produces a spinally mediated opioid antinociception for the inflamed hindpaw of the rat. Brain Res 545:17-23.
20. Mousa SA (2003) Morphological correlates of immune-mediated peripheral opioid analgesia. Adv Exp Med Biol 521:77-87.
21. Perrot S, Guilbaud G, and Kayser V (1999) Effects of intraplantar morphine on paw edema and pain-related behaviour in a rat model of repeated acute inflammation. Pain 83:249-257.
22. Planas ME, Rodriguez L, Sanchez S, Pol O, and Puig MM (1995) Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain 60:67-71.
23. Romero A, Planas E, Poveda R, Sánchez S, Pol O, and Puig MM (2005) Antiexudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw. Eur J Pharmacol 511:207-217.
24. Sacerdote P, Bianchi M, and Panerai AE (1996) Involvement of β-endorphin in the modulation of paw inflammatory edema in the rat. Regul Pept 63:79-83.
25. Selley DE, Breivogel CS, and Childer SR (1993) Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 44:731-741.
26. Stanojević S, Radulović J, Kovaèević- Jovanović V, Vujić V, and Dimitrijević M (2002) Different effects of methionine-enkephalin on paw edema in two inbred rat strains. Peptides 23:1597-1605.
27. Stein A, Yassouridis A, Szopko C, Helmke K, and Stein C (1999) Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83:525-532.
28. Stein C, Millan MJ, Shippenberg TS, and Herz A (1988) Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neurosci Lett 84:225-228.
29. Stein C, Schäfer M, and Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003-1008.
30. Taylor BK, Peterson MA, Roderick RE, Tate J, Green PG, Levine JO, and Basbaum AI (2000) Opioid inhibition of formalin-induced changes in plasma extravasation and local blood flow in rats. Pain 84:236-270.
31. Valenzano KJ, Miller W, Chen Z, Shan S, Crumley G, Victory SF, Davies E, Huang J, Allie N, Rotstheyn Y, et al. (2004) DiPOA ([8-(3,3-diphenyl-propyl)-4- oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid), a peripherally-acting μ agonist with anti-hyperalgesic properties: 1. In vitro pharmacological characterization and pharmacokinetic properties. J Pharmacol Exp Ther 310:783-792.
32. Victory SF and Chen Z (2003) inventors, Euro-Celtique SA, assignee. Triazaspiro compounds useful for treating or preventing pain. WO patent 03101953. 2003 Dec 11.
33. Vujić-Redzić V, Dimitrijević M, Stanojević S, Kovaèević-Jovanović, V, Miletic T, and Radulović (2000) Peripheral effects of methionine-enkephalin on inflammatory reactions and behavior in the rat. Neuroimmunomodulation 8:70-77.
34. Walker JS, Chandler AK, Wilson JL, Binder W, and Day RO (1996) Effect of μ-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats. Inflamm Res 45:299-302.
35. Wang H and Wessendorf MW (2001) Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol 429:590-600.
36. Wenk HN, Nannenga MN, and Honda CN (2003) Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea. Pain 105:455-465.
37. Whiteside GT, Harrison JE, Pearson MS, Chen Z, Rotshteyn Y, Turchin PI, Pomonis JD, Mark L, Walker K, and Broglé K (2004) DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl] -acetic acid), a novel, peripherallyrestricted μ opioid agonist with anti-hyperalgesic activity: 2. In vivo pharmacological characterization in the rat. J Pharmacol Exp Ther 310:793-799.
38. Yaksh TL (1999) Textbook of Pain (Wall PD and Melzack R eds) pp 253-308, Churchill Livingstone, Edinburg, UK.
39. Zhou L, Zhang Q, Stein C, and Schäfer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286:1000-1006.
40. Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, and Schäfer M (2003) Painful inflammation-induced increase in μ-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202-210.